Radiotherapy for early glottic carcinoma (T1N0M0): Results of prospective randomized study of radiation fraction size and overall treatment time

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 1, 2006, Pages 77-82

  Yamazaki, Hideya ^a   Nishiyama, Kinji ^a   Tanaka, Eiichi ^a   Koizumi, Masahiko ^b   Chatani, Masashi ^c  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

^c OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

Early glottic carcinoma; Fraction size; Overall treatment time

Indexed keywords

EARLY GLOTTIC CARCINOMA; FRACTION SIZE; OVERALL TREATMENT TIME;

DOSIMETRY; PATIENT TREATMENT; RADIATION EFFECTS; RADIOTHERAPY; SKIN; TUMORS;

CARCINOGENS;

ADULT; AGED; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SURVIVAL RATE; TIME SERIES ANALYSIS; VOCAL CORD;

AGED; EPIDEMIOLOGIC METHODS; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SALVAGE THERAPY; SURVIVAL RATE; TIME FACTORS;

EID: 29244458641     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.06.014     Document Type: Conference Paper

References (15)

1. D.A. Fein, W.R. Lee, A.L. Hanlon Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? Int J Radiat Oncol Biol Phys 34 1996 823 831
2. Q.T. Le, K.K. Fu, S. Kroll Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma Int J Radiat Oncol Biol Phys 39 1997 115 126
3. M. Chatani, Y. Matayoshi, N. Masaki Radiation therapy for larynx carcinoma Long-term results of Stage I glottic carcinoma Strahlenther Onkol 169 1993 102 106
4. M.S. Rudoltz, A. Benammar, M. Mohiuddin Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis Int J Radiat Oncol Biol Phys 26 1993 767 772
5. J.C. van der Voet, R.B. Keus, A.A. Hart The impact of treatment time and smoking on local control and complications in T1 glottic cancer Int J Radiat Oncol Biol Phys 42 1998 247 255
6. L.S. Burke, K.M. Greven, W.T. McGuirt Definitive radiotherapy for early glottic carcinoma Prognostic factors and implications for treatment Int J Radiat Oncol Biol Phys 38 1997 1001 1006
7. M. Chatani, Y. Matayoshi, N. Masaki Radiation therapy for early glottic carcinoma (T1N0M0) The adverse effect of treatment interruption Strahlenther Onkol 173 1997 502 506
8. E. Yu, G. Shenouda, M.P. Beaudet Impact of radiation therapy fraction size on local control of early glottic carcinoma Int J Radiat Oncol Biol Phys 37 1997 587 591
9. W.M. Mendenhall, J.W. Werning, R.W. Hinemann Management of T1-2 glottic carcinoma Cancer 100 2004 1786 1792
10. G. Kok Influence of the size of the fraction dose on normal and tumor tissue in cobalt-60 radiation treatment of carcinoma of the larynx and inoperable carcinoma of the breast Radiol Clin Biol 40 1971 100 115
11. W.M. Mendenhall, J.T. Parsons, R.R. Million T1-2 squamous cell carcinoma at the glottic larynx treated with radiation therapy Relationship of dose fraction factors to local control and complications Int J Radiat Oncol Biol Phys 5 1988 1267 1273
12. Y. Nishimura, Y. Nagata, K. Okajima Radiation therapy for T1-2 glottic carcinoma Impact of overall treatment time on local control Radiother Oncol 40 1996 225 232
13. A.R. Harwood, A. Tierie Radiotherapy of early glottic cancer - II Int J Radiat Oncol Biol Phys 5 1979 473 476
14. M.E. Randall, D.J. Springer, M. Raben T1-2 carcinoma of the glottis Relative hypofraction Radiology 179 1991 569 571
15. J. Overgaard, H.S. Hansen, L. Specht Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck DAHANCA 6 and 7 randomised controlled trial Lancet 20 2003 933 940